GSG Advisors LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 6,005 shares of the company's stock, valued at approximately $2,901,000. Astera Labs comprises about 0.6% of GSG Advisors LLC's investment portfolio, making the stock its 25th biggest position.
Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company's stock valued at $2,300,344,000 after purchasing an additional 84,365 shares in the last quarter. BlackRock Inc. acquired a new stake in shares of Astera Labs during the second quarter worth $6,609,581,000. Atreides Management LP lifted its stake in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock worth $368,890,000 after buying an additional 1,754,593 shares during the period. State Street Corp grew its holdings in shares of Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company's stock valued at $515,684,000 after buying an additional 760,358 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Astera Labs by 4.5% during the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company's stock valued at $403,598,000 after buying an additional 104,935 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Astera Labs
In other news, CEO Jitendra Mohan sold 90,630 shares of the business's stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief executive officer owned 1,266,665 shares of the company's stock, valued at $431,109,432.75. The trade was a 6.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 136,974 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the transaction, the director directly owned 1,287,524 shares of the company's stock, valued at $569,098,483.24. The trade was a 9.62% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 419,244 shares of company stock worth $163,135,169. Insiders own 10.40% of the company's stock.
Astera Labs Price Performance
NASDAQ:ALAB opened at $284.97 on Monday. The firm has a market capitalization of $49.44 billion, a P/E ratio of 141.07 and a beta of 3.84. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The company's fifty day moving average price is $352.70 and its 200-day moving average price is $245.57.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. During the same quarter last year, the company posted $0.44 earnings per share. The firm's revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on the company. Stifel Nicolaus raised their target price on Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a research note on Wednesday, June 24th. Barclays lifted their price target on Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a research report on Monday, July 20th. JPMorgan Chase & Co. boosted their price target on Astera Labs from $205.00 to $280.00 and gave the company an "overweight" rating in a research note on Wednesday, May 6th. Evercore reissued an "outperform" rating and issued a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Finally, Susquehanna raised their price objective on Astera Labs from $230.00 to $275.00 and gave the stock a "neutral" rating in a research note on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $333.00.
Read Our Latest Research Report on ALAB
About Astera Labs
(
Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report